Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04865562 · ClinicalTrials.gov registry record · Phase 4
Hormones and Decision Making
A Phase 4 study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT04865562 is a Phase 4 study that has completed, run by University of Texas at Austin. The registered enrollment target is 30 participants.
The verdict
NCT04865562, a Phase 4 study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
An investigation of the neuropsychological processes underlying ethical decision making.
Interventions
- DRUG testosterone propionate
- DRUG 0.5% cholorbutanol, saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-03-01 |
| Est. Completion | 2016-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04865562
The ClinicalTrials.gov registry entry for NCT04865562 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which testosterone propionate is the first listed.
NCT04865562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04865562 about?
NCT04865562 is a clinical study titled "Hormones and Decision Making". An investigation of the neuropsychological processes underlying ethical decision making.
What is the current status of trial NCT04865562?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2015-03-01. Estimated completion is 2016-09-01.
What interventions are being tested in trial NCT04865562?
The interventions under investigation include: testosterone propionate (DRUG), 0.5% cholorbutanol, saline (DRUG).
Who is sponsoring clinical trial NCT04865562?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.